Advances in the management of pulmonary arterial hypertension
Open Access
- 1 October 2021
- journal article
- review article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 69 (7) , 1270-1280
Abstract
The management of pulmonary arterial hypertension (PAH) has significantly evolved over the last decades in the wake of more sensitive diagnostics and specialized clinical programs that can provide focused medical care. In the current era of PAH care, 1-year survival rates have increased to 86%–90% from 65% in the 1980s, and average long-term survival has increased to 6 years from 2.8 years. The heterogeneity in the etiology and disease course has opened doors to focusing research in phenotyping the disease and understanding the pathophysiology at a cellular and genetic level. This may eventually lead to precision medicine and the development of medications that may prevent or reverse pulmonary vascular remodeling. With more insight, clinical trial designs and primary end-points may change to identify the true survival benefit of pharmacotherapy. Identifying responders from non-responders to therapy may help provide individualized patient-centered care rather than an algorithm-based approach. The purpose of this review is to highlight the latest advances in screening, diagnosis, and management of PAH.Keywords
This publication has 88 references indexed in Scilit:
- Cardiopulmonary Exercise Testing Reveals Onset of Disease and Response to Treatment in a Case of Heritable Pulmonary Arterial HypertensionPulmonary Circulation, 2012
- Lung Transplantation for Pulmonary HypertensionPulmonary Circulation, 2011
- Cardiopulmonary Exercise Testing with Right-heart Catheterization in Patients with Systemic SclerosisThe Journal of Rheumatology, 2010
- Therapy for pulmonary arterial hypertension associated with systemic sclerosisCurrent Opinion in Rheumatology, 2009
- International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2006
- Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary HypertensionChest, 2006
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 2005
- Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2European Respiratory Journal, 2004
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 2003
- Survival in Primary Pulmonary HypertensionCirculation, 2002